Using ex vivo explants from estrogen receptor-positive, estrogen receptor mutant, and triple-negative breast cancer patients, we demonstrate that CB blocks breast cancer growth and metastasis without affecting normal breast tissue. The gene discussed is ESR1; the disease is breast carcinoma.